{"entity":{"type":"insider","cik":"0001321326","url":"/insider/0001321326","json_url":"/insider/0001321326.json","name":"Stacey Jennifer Evans","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":5,"first":"2005-11-30","last":"2009-09-16","span_basis":"filed_date"},"name_variants":[{"name":"Stacey Jennifer Evans","source":"filing","n_filings":5,"first_seen":"2005-11-30","last_seen":"2009-09-16"}],"transactions":[{"id":6089679,"accession":"0001209191-09-044653","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-09-044653","line_url":"/filing/0001209191-09-044653#line-4","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001321326","owner_name":"Stacey Jennifer Evans","owner_display_name":"Stacey Jennifer Evans","owner_url":"/insider/0001321326","role":"Officer (Executive VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Executive VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6333.0,"shares_display":"6,333","price_per_share":35.4318,"price_display":"35.43","price_state":"stated","total_value":224389.5894,"total_display":"224,389.59","total_whole":"224,390","shares_owned_after":9382.0,"shares_owned_after_display":"9,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-09-14","filed_date":"2009-09-16","scope":"insider"},{"id":5693845,"accession":"0001209191-09-037948","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-09-037948","line_url":"/filing/0001209191-09-037948#line-4","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001321326","owner_name":"Stacey Jennifer Evans","owner_display_name":"Stacey Jennifer Evans","owner_url":"/insider/0001321326","role":"Officer (Executive VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Executive VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6333.0,"shares_display":"6,333","price_per_share":32.1284,"price_display":"32.13","price_state":"stated","total_value":203469.1572,"total_display":"203,469.16","total_whole":"203,469","shares_owned_after":9382.0,"shares_owned_after_display":"9,382","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-07-24","filed_date":"2009-07-28","scope":"insider"},{"id":5759498,"accession":"0001209191-09-002469","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-09-002469","line_url":"/filing/0001209191-09-002469#line-4","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001321326","owner_name":"Stacey Jennifer Evans","owner_display_name":"Stacey Jennifer Evans","owner_url":"/insider/0001321326","role":"Officer (Executive VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Executive VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5970.0,"shares_display":"5,970","price_per_share":30.0398,"price_display":"30.04","price_state":"stated","total_value":179337.606,"total_display":"179,337.61","total_whole":"179,338","shares_owned_after":6515.0,"shares_owned_after_display":"6,515","ownership_form":"D","is_10b5_1":null,"transaction_date":"2009-01-06","filed_date":"2009-01-08","scope":"insider"},{"id":3661916,"accession":"0001209191-08-067052","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-08-067052","line_url":"/filing/0001209191-08-067052#line-2","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001321326","owner_name":"Stacey Jennifer Evans","owner_display_name":"Stacey Jennifer Evans","owner_url":"/insider/0001321326","role":"Officer (Executive VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Executive VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP & General Counsel","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":27.5944,"price_display":"27.59","price_state":"stated","total_value":137972.0,"total_display":"137,972.00","total_whole":"137,972","shares_owned_after":6515.0,"shares_owned_after_display":"6,515","ownership_form":"D","is_10b5_1":null,"transaction_date":"2008-12-18","filed_date":"2008-12-22","scope":"insider"},{"id":1266270,"accession":"0001209191-05-060147","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-05-060147","line_url":"/filing/0001209191-05-060147","is_derivative":false,"issuer_cik":"0001182129","issuer_name":"AUXILIUM PHARMACEUTICALS INC","issuer_ticker":"AUXL","issuer_name_source":null,"issuer_url":"/issuer/0001182129","owner_cik":"0001321326","owner_name":"Stacey Jennifer Evans","owner_display_name":"Stacey Jennifer Evans","owner_url":"/insider/0001321326","role":"Officer (Executive VP & General Counsel)","role_mark":"O","role_mark_label":"Officer (Executive VP & General Counsel)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive VP & General Counsel","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":5.31236,"price_display":"5.31","price_state":"stated","total_value":26561.8,"total_display":"26,561.80","total_whole":"26,562","shares_owned_after":4900.0,"shares_owned_after_display":"4,900","ownership_form":"D","is_10b5_1":null,"transaction_date":"2005-11-28","filed_date":"2005-11-30","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001182129","name":"AUXILIUM PHARMACEUTICALS INC","url":"/issuer/0001182129","role":"Officer (Executive VP & General Counsel)","n_filings":5,"first_seen":"2005-11-30","last_seen":"2009-09-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001321326","retrieved_at":"2026-08-26T05:14:17+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}